Abn Amro Investment Solutions Zai Lab LTD Transaction History

Abn Amro Investment Solutions

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Sep 04, 2025	BUY	$13.72 - $21.55 $748,426 - $1.18 Million	54,550 New	54,550 $945 Million
Q1 2024 Sep 05, 2025	BUY	$15.95 - $26.8 $55,521 - $93,290	3,481 Added 6.82%	54,550 $874 Million
Q3 2023 Nov 07, 2025	BUY	$22.72 - $31.49 $1.16 Million - $1.61 Million	51,069 New	51,069 $1.24 Billion
Q3 2023 Sep 05, 2025	SELL	$22.72 - $31.49 $131,185 - $181,823	-5,774 Reduced 10.16%	51,069 $1.24 Billion
Q1 2023 Sep 05, 2025	BUY	$30.21 - $48.1 $1.72 Million - $2.73 Million	56,843 New	56,843 $1.89 Billion

153

32.7M

168K

222K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.13B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Abn Amro Investment Solutions, based on Form 13F filings with the SEC.

Stay updated on Abn Amro Investment Solutions with notifications on news.